The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
STAT Plus: Vampiric cancer cells, a brain atlas, & alleged misconduct at Cassava
STAT Plus: Cell and gene therapies could be a safer bet than other drugs
STAT Plus: With Ozempic, Wall Street moves on from a whole other class of medicines
STAT Plus: Want a biotech buyout? Target cancer
STAT Plus: NIH funds expanded access projects for ALS
Moderna’s plan to make a single vaccine for Covid, influenza, and RSV is on track
